UnitedHealth Group (UNH) Issues Earnings Results

UnitedHealth Group (NYSE:UNH) issued its earnings results on Tuesday. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09, Bloomberg Earnings reports. The business had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.11 EPS.

UnitedHealth Group (UNH) opened at $232.91 on Tuesday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. UnitedHealth Group has a one year low of $156.09 and a one year high of $234.78. The stock has a market cap of $226,100.00, a P/E ratio of 26.47, a PEG ratio of 1.54 and a beta of 0.66.

A number of brokerages have commented on UNH. Leerink Swann restated a “buy” rating and issued a $240.00 target price (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price on the stock in a research note on Thursday, September 21st. Cantor Fitzgerald upped their target price on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. Oppenheimer upped their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 18th. Finally, Wells Fargo & Co restated an “outperform” rating and issued a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $229.54.

In related news, Director Michele J. Hooper sold 5,000 shares of the stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the completion of the sale, the director now owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Thomas E. Roos sold 975 shares of the stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the sale, the insider now directly owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 34,630 shares of company stock worth $7,669,416. Insiders own 0.89% of the company’s stock.

A number of large investors have recently bought and sold shares of the stock. Blue Chip Partners Inc. purchased a new position in shares of UnitedHealth Group in the second quarter worth $110,000. Bruderman Asset Management LLC purchased a new position in shares of UnitedHealth Group in the second quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after buying an additional 520 shares during the last quarter. BDO Wealth Advisors LLC purchased a new position in shares of UnitedHealth Group in the second quarter worth $121,000. Finally, Acrospire Investment Management LLC raised its holdings in shares of UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after buying an additional 400 shares during the last quarter. 86.09% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece was published by Transcript Daily and is owned by of Transcript Daily. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://transcriptdaily.com/2018/01/16/unitedhealth-group-unh-issues-earnings-results.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply